New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition

[Display omitted] •The new intermediates new 6a&b and the target new pyrimidines 7a&b were designed and prepared.•The structure of new targets was proved using NMR, IR and elemental analysis.•The cytotoxicity, antioxidant, phospholipase A2-V and cyclooxygenases inhibitory activities of 7a&am...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic chemistry Vol. 92; p. 103218
Main Authors: Abdelgawad, Mohamed A., Bakr, Rania B., Ahmad, Waqas, Al-Sanea, Mohammad M., Elshemy, Heba A.H.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-11-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •The new intermediates new 6a&b and the target new pyrimidines 7a&b were designed and prepared.•The structure of new targets was proved using NMR, IR and elemental analysis.•The cytotoxicity, antioxidant, phospholipase A2-V and cyclooxygenases inhibitory activities of 7a&b were evaluated.•The docking of 7a&b was made to confirm the mechanism of action. To enhance the cytotoxicity of benzimidazole and/or benzoxazole core, the benzimidazole/benzoxazole azo-pyrimidine were synthesized through diazo-coupling of 3-aminophenybenzimidazole (6a) or 3-aminophenylbenzoxazole (6b) with diethyl malonate. The new azo-molanates 6a&b mixed with urea in sodium ethoxide to afford the benzimidazolo/benzoxazolopyrimidine 7a&b. The structure elucidation of new synthesized targets was proved using spectroscopic techniques NMR, IR and elemental analysis. The cytoxicity screening had been carried out against five cancer cell lines: prostate cancer (PC-3), lung cancer (A-549), breast cancer (MCF-7), pancreas cancer (PaCa-2) and colon cancer (HT-29). Furthermore, the antioxidant activity, phospholipase A2-V and cyclooxygenases inhibitory activities of the target compounds 7a&b were evaluated and the new compounds showed potent activity (cytotoxicity IC50 range from 4.3 to 9.2 µm, antioxidant activity from 40% to 80%, COXs or LOX inhibitory activity from 1.92 µM to 8.21 µM). The docking of 7a&b was made to confirm the mechanism of action.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0045-2068
1090-2120
DOI:10.1016/j.bioorg.2019.103218